New Preliminary Efficacy Data for Daratumumab Presented at ASH

[at noodls] – Company Announcement Preliminary safety and efficacy data from final patients in part 1 of study continue to be encouraging Data presented in oral presentation today at the ASH Annual Meeting Part 2 of … more

View todays social media effects on GENC

View the latest stocks trending across Twitter. Click to view dashboard

See who Gencor is hiring next, click here to view